Background {#Sec1}
==========

Despite major advances in clinical research and medical technology, the prevalence of adverse maternal and neonatal health outcomes, such as pre-eclampsia and preterm birth, have only moderately decreased over the past decade \[[@CR1]\]. As the first few weeks of pregnancy are crucial for gametogenesis, organogenesis and placental development, there is growing evidence that exposure to unhealthy lifestyle behaviours before or during pregnancy (such as alcohol consumption, smoking, physical inactivity, excessive weight gain, obesity and poor nutrition), often affect the future health of mothers, their offspring and future generations \[[@CR2]--[@CR4]\]. In the Netherlands, 85% of all pregnancies are planned pregnancies \[[@CR5]\]. However, planning a pregnancy is not always accompanied by appropriate preparation for pregnancy. As such, only half of all pregnant women use folic acid in the correct dose for the correct amount of time and more than 60% of all women with a wish to conceive still use alcohol \[[@CR5]\]. A recent study among future fathers showed that the majority of them took no action to improve their lifestyle behaviours before conception \[[@CR6]\]. Therefore, it is important to improve awareness among prospective parents regarding (unhealthy) preconceptional lifestyle behaviours and its effect on reproductive outcomes and to encourage prospective parents to actively prepare for pregnancy.

One way to actively prepare for pregnancy is by using preconception care (PCC). PCC is defined as "a set of interventions that aim to identify and modify medical, behavioural and social risks to a woman's health or pregnancy outcome through prevention and management" \[[@CR7]\]. Despite a growing body of evidence showing that PCC can increase the health and well-being of prospective parents, the uptake of PCC-consults remains remarkably low \[[@CR8]\]. Even more cause for concern is that vulnerable women, who often have multiple unhealthy lifestyle behaviours, are specifically hard to reach \[[@CR9]\]. Previous studies have shown that barriers for the use of PCC are determined by the presence of preconditions, women's beliefs, perceptions and experiences, given the limited availability and the inadequate infrastructure in which PCC is provided \[[@CR10], [@CR11]\]. Previously developed PCC-interventions tend to be clinical and focus on individual-level behaviour change (i.e. counselling women not to engage in risky behaviours) rather than examining social, structural and environmental factors that shape preconception health \[[@CR12]\].

A previous feasibility study performed by our group (APROPOS) in one municipality of the Netherlands showed that a locally tailored PCC-approach has the potential to positively affect preconceptional lifestyle behaviours and increases the use of PCC among prospective parents \[[@CR13]\]. After being exposed to the intervention, women were more likely to make at least one preconceptional lifestyle behaviour change compared to women who were not exposed to the intervention (adjusted OR 1.56 (95%CI 1.02--2.39)) \[[@CR13]\]. However, before this locally tailored intervention can be implemented on an (inter)national level, the feasibility and effectiveness of this intervention needs to be analysed in a larger-scale implementation study. Therefore, we designed a second study (APROPOS-II) with implementation in more municipalities, a larger group of respondents, randomization, and assessment of a more comprehensive set of (clinical) outcomes.

Aims and objectives {#Sec2}
-------------------

The aim of this study is to assess the effectiveness and the implementation process of a local PCC-approach (i.e. the intervention) on preconceptional lifestyle behaviours, health outcomes and the reach of PCC among prospective parents and healthcare providers. Therefore, we have specified the following objectives: To determine the effect of the intervention on preconceptional lifestyle behaviours (e.g. smoking, alcohol use, folic acid use, physical activity) and other risk factors (e.g. body mass index, psychological distress, chronic illness) among women who recently conceived;to assess the effect of the intervention on the reach of prospective parents regarding PCC, the uptake of PCC and pregnancy preparation;to evaluate the implementation process in order to gain information on the feasibility, barriers and facilitators for the implementation of the local PCC-approach;to evaluate the sustainability of the intervention, with a specific focus on the diversity within and between the participating municipalities.

Methods / design {#Sec3}
================

Study design {#Sec4}
------------

The APROPOS-II study uses a hybrid effectiveness-implementation design \[[@CR14], [@CR15]\]. In a stepped-wedge cluster-randomized controlled trial (RCT) we will implement and evaluate the effectiveness of the intervention. Randomization occurs at a cluster-level instead of an individual-level because the intervention has a community-approach in which the entire target population will be exposed to the intervention. All participating municipalities start with a control-phase, which will last 6--16 months depending on randomization order. The total duration of the study is 30 months (Fig. [1](#Fig1){ref-type="fig"}). The RE-AIM (reach, effectiveness, adoption, implementation, maintenance) framework will be used to evaluate the intervention and the implementation strategy \[[@CR16]\]. Fig. 1Timeline of the APROPOS-II study. All participating municipalities start with a control-phase, which will last 6--16 months depending on randomization order. After the control phase, the intervention will be implemented stepwise in every municipality

Study population and setting {#Sec5}
----------------------------

The study will be conducted in six municipalities distributed throughout the Netherlands (i.e. Amersfoort, Barneveld, Deventer, Tilburg, Utrecht and Zoetermeer). In total, ten community midwifery practices in these municipalities participate in the study. Municipalities were selected for diversity regarding their size (varying from 57,000--211,000 inhabitants), population, health challenges and organization of care. All women above the age of 18 years who adequately master the Dutch, English, Polish or Turkish language are eligible to participate in this study. Men are recruited through their participating partners.

Our intervention targets all men and women in their reproductive life span. In all six participating municipalities together, this is approximately 270,000 people \[[@CR17]\]. Figure [2](#Fig2){ref-type="fig"} shows how the number of people in the target population results in the total number of respondents. Fig. 2Overview of the studypopulation of the APROPOS-II study. This figure shows how the number of people in the target population results in the total number of respondents for the APROPOS-II study. The intervention targets all men and women in their reproductive life span within a municipality. We aim to include 2267 women in the study

Intervention {#Sec6}
------------

The intervention used in this study is a PCC-approach tailored to the needs of prospective parent(s) and healthcare providers in a local setting. This intervention has been developed based on pre-implementation research in the APROPOS feasibility study \[[@CR13]\]. The intervention has a dual-track approach based on both the uptake and the provision of PCC. Uptake of PCC: To improve preconceptional lifestyle behaviours and the uptake of PCC, a social marketing strategy, directed towards prospective parent(s), will be distributed in each participating municipality. This online and offline social marketing strategy aims to trigger prospective parents to actively prepare for pregnancy by directing them towards reliable PCC-information and promoting individual PCC-consults.Provision of PCC: To improve interdisciplinary collaboration among healthcare providers, a local care pathway will be developed and implemented in each participating municipality, including interdisciplinary arrangements for collaboration and referral between primary, secondary and tertiary care. Moreover, a working conference will be held among local healthcare providers of multidisciplinary backgrounds and a stakeholder coalition will be formed.

Implementation of the intervention {#Sec7}
----------------------------------

Concerning the uptake of PCC, the social marketing strategy has been developed by a professional and experienced marketing agency. A social marketing strategy uses commercial marketing technologies to design programs that can influence the behaviour of the target audience in order to improve personal welfare and that of society \[[@CR18]\]. The theoretical foundation for this social marketing strategy is based on research regarding the target population's perception from biological-, emotional-, social- and cultural point of views and resulted in the concept of "Woke Women®", with the single-minded proposition: "Wake up smart (future) Mama! Let's make your baby strong". The social marketing strategy uses different channels of communication, e.g. online marketing, traditional offline marketing channels, word-of-mouth marketing and social networks will be addressed to start a social movement. Its purpose is to use existing social networks to encourage women to motivate each other towards healthy behaviour. Examples of materials used in the social marketing strategy are shown in Fig. [3](#Fig3){ref-type="fig"} and more information about the social marketing strategy can be found on [www.wokewomen.nl](http://www.wokewomen.nl) (in Dutch). Fig. 3Sociale marketing strategy Woke Women®. Examples of the promotional material (visuals) of the social marketing strategy Woke Women® which has been specifically developed for this study

Regarding the provision of PCC, the working conference for the healthcare providers aims to educate them on preconceptional health and risk factors using the national Preconception Indication List (PIL), emphasizes the importance of facilitating PCC and is used to conduct a region-specific bottleneck analysis \[[@CR5]\] \[[@CR19]\]. Subsequently, a multidisciplinary group of healthcare providers will form a local stakeholder coalition. With the input of these stakeholders, the intervention will be tailored to the participating municipality prior to implementation by adapting the dissemination locations, the design of the intervention and the essential elements included in the intervention.

Clinical parameters and outcomes {#Sec8}
--------------------------------

Study parameters will be assessed by a questionnaire distributed among prospective parent(s) by the participating community midwifery practices in the first trimester of pregnancy. The questionnaire is based on validated questionnaires such as WHO - Quality of life questionnaire, the London Measure of Unplanned Pregnancy (LMUP), a validated preconception tool ([www.zwangerwijzer.nl](http://www.zwangerwijzer.nl)) and the APROPOS feasibility study \[[@CR20], [@CR21]\]. The questionnaire contains five sections: pregnancy planning, pregnancy preparation, healthy lifestyle behaviours and risk factors, personal situation and the prospective father. There are two versions of the questionnaire, one pre-implementation and one post-implementation. The post-implementation questionnaire contains additional evaluation questions about participant's experiences with the social marketing strategy. An overview of all the variables in the questionnaire is shown in Table [1](#Tab1){ref-type="table"}. The questionnaire is available in Dutch, English, Polish and Turkish; languages that are mastered by the majority of the inhabitants of the participating municipalities. The questionnaire for prospective fathers is shorter compared to the questionnaire for pregnant women and solely focusses on lifestyle behaviours and health beliefs. Table 1Definition of primary and secondary outcomes of the APROPOS-II studyVariableDefinition\*Pregnancy preparationLevel of pregnancy planningLondon Measure of Unplanned Pregnancies (LMUP) \[[@CR21]\]PCC health seeking behaviourAcquired PCC-information through the internet, books, journals, folders or family & friends.PCC-consultA consultation provided by a healthcare provider.Modifying lifestyle behaviours & risk factorsFruit intake≥ 2 pieces of fruit a day \[[@CR22]\]Vegetable intake≥ 200 g of vegetables a day \[[@CR22]\]Caffeine intake≤ 1 caffeine-containing beverage \[[@CR22]\]Exercising≥ 150 min per week moderate or heavy intensive exercise, spread over various days \[[@CR23]\]SmokingNo smoking \[[@CR5], [@CR24]\]Alcohol intakeNo alcohol intake \[[@CR5], [@CR24]\]Folic acid usage≥400 microgram per day, 4 weeks preconceptionally until 10 weeks gestation \[[@CR5], [@CR24]\]Medication usageRisk-free medication \[[@CR5]\]Psychological distressA stable emotional state \[[@CR5]\]Vaccination statusVaccination status should be discussed with special attention to rubella, measles and whooping cough. Based on individual assessment of antibody titres; (re)vaccinations can be considered \[[@CR24]\]Working conditionsAvoid contact with harmful working conditions \[[@CR5]\]Prenatal outcomesMiscarriageLoss of pregnancy before 24 weeks \[[@CR25]\].Gestational Diabetes (GDM)Diagnosed by a 75-g oral glucose tolerance test (OGTT) as the presence of either a fasting glucose level of ≥7.0 mmol/L (126 mg/dl) or a glucose level of ≥7.8 mmol/L (140 mg/dl) after two hours \[[@CR26], [@CR27]\]Pregnancy-induced hypertension (PIH)New onset of hypertension (≥ 140 mmHg systolic and/or ≥ 90 mmHg diastolic blood pressure) after 20 weeks gestation measured on at least two occasions four hours apart \[[@CR28], [@CR29]\]Pre-eclampsia (PE)PIH accompanied by proteinuria (≥300 mg in 24 h) \[[@CR29], [@CR30]\]Spontaneous preterm birthDelivery with spontaneous onset before 37 weeks of gestation \[[@CR31]\].Referral to secondary careIf complications occur or threaten to occur, the midwife will refer the woman to the obstetrician who will take over the care for as long as deemed necessary \[[@CR32]\].Birth outcomesMode of deliverySpontaneous vaginal delivery, assisted vaginal delivery, or caesarean section \[[@CR33]\].Referral to secondary careIf complications occur or threaten to occur, the midwife will refer the woman to the obstetrician who will take over the care for as long as deemed necessary \[[@CR32]\].Neonatal outcomesSmall for gestational age (SGA)Birth weight \< 10th percentile, based on Dutch national reference curves adjusted for parity, gestational age, sex and ethnicity \[[@CR34]\].Congenital anomaliesStructural-morphological, functional and/or biochemical-molecular defectspresent at birth \[[@CR35]\].APGAR- scoreA score is a sum of the values assigned to the infant at 1 and 5 min of life, with a score of 7 or more indicating that the baby is in good to excellent condition \[[@CR36]\].***\**** *Definitions are based on Dutch standards*

The primary outcome of this study is change in lifestyle behaviours. This is a composite outcome of four modifiable lifestyle behaviours (healthier diet, folic acid use, quit drinking and quit smoking during the preconception period), expressed as the number of women who preconceptionally change at least one of these lifestyle behaviours from inadequate to adequate. The definitions of healthy lifestyle behaviour are based on Dutch guidelines and are provided in Table [1](#Tab1){ref-type="table"}.

Secondary outcomes are pregnancy outcomes (e.g. miscarriage, preterm birth, gestational diabetes) and the uptake of PCC. The definitions of these pregnancy outcomes are given in Table [1](#Tab1){ref-type="table"} and will be collected from the participants' medical records after obtaining additional informed consent. The uptake of PCC will be measured through a section in the questionnaire and by the records of the midwifery practices on PCC-consults.

Implementation parameters and outcomes {#Sec9}
--------------------------------------

The RE-AIM framework will be used to evaluate the intervention and the implementation strategy. This framework is a practical way of evaluating health interventions and has previously been used in studies focused on changing individual behaviours \[[@CR16]\]. Regarding patient implementation outcomes, the respondents' satisfaction towards the PCC-consults will be assessed by elements of the validated ReproQ, which is based on the WHO-concept responsiveness and has been incorporated in our questionnaire \[[@CR37], [@CR38]\].

Healthcare providers' implementation outcomes will be measured by a 23-item validated NoMAD (Normalisation MeAsure Development) questionnaire. The NoMAD questionnaire will be used to describe the health care providers' views on how the intervention impacts their work and their expectations about whether the intervention could become a routine part of their work \[[@CR39]\]. The healthcare providers will receive this questionnaire 3 months before the start of the intervention-phase and a follow-up questionnaire 6 months later. Barriers and facilitators regarding the implementation of the PCC-approach will be collected among healthcare providers and classified using the Flottorp et al. - checklist \[[@CR40]\].

Finally, the feasibility of the implementation of the local care pathways will be evaluated among healthcare providers. We will measure to what degree the local care pathway was distributed amongst the healthcare providers and how healthcare providers experienced the convenience of this tool. In each municipality, focus groups with the local stakeholder coalition will be held 9 months after the start of the intervention and will be analysed using thematic analysis to identify key issues and themes. In these focus groups, information will be gathered on how the intervention complies with the heterogeneity of local settings, since differences in healthcare networks, logistics and practical issues call for tailored approaches.

Sample size calculation {#Sec10}
-----------------------

Based on the results from the APROPOS feasibility study, we anticipate on an odds ratio of 1.5 in lifestyle behaviour change during the preconception period (primary outcome). Based on the sample size estimation method of Hemming and Taljaard, with an alpha of 0.05, power of 80% and a low intraclass correlation Coefficient of 0.02, the sample size was calculated to be 363 participants per unit with 6 units (=municipalities; 2167 in total, 23 participants per month per municipality) \[[@CR41]\]. Considering our inclusion criteria, almost all women who have their intake visit during the study period are eligible respondents. Based on previous experience, we expect that 50--60% of these women will fill out the questionnaire.

Statistical analysis {#Sec11}
--------------------

Statistical analysis will be performed using multilevel logistic regression analysis to take into account the clustering of respondents within municipalities. Data will be analysed anonymously on two levels; the respondents' level (before and after the intervention) and the municipal level (differences between municipalities). Baseline characteristics will be compared between the pre- and post-intervention group and compared in a baseline table. Chi-square analysis and ANCOVA will be used to study the effects of the intervention on the adverse pregnancy outcomes. Adjusted odds ratios will be calculated taking into account the potential confounders: age, educational level and parity. *P*-values \< 0.05 are considered statistically significant.

Discussion {#Sec12}
==========

The APROPOS-II study introduces a locally tailored PCC-approach in six municipalities in the Netherlands, that will contribute to current knowledge regarding the implementation and the effectiveness of PCC. Until now there is little data from randomized clinical trials that prove the effectiveness of PCC on maternal and perinatal health outcomes \[[@CR3], [@CR42], [@CR43]\]. This evidence is necessary to substantiate the urgency to invest in a comprehensive (inter)national PCC-program. The presented intervention serves the different needs of prospective parents by providing both separate preconception health information and PCC-consultation. This supports the view that most prospective parents will benefit from evidence-based information to prepare themselves for pregnancy, while not every prospective parent will attend a PCC-consult.

Despite the low uptake of PCC-consults, the majority of prospective parents use the internet as their primary source of information regarding preconception health \[[@CR11]\]. Women appreciate anonymity and self-management of online information in the privacy of their own home \[[@CR11], [@CR44]\]. The aim of the social marketing strategy in this intervention is to trigger women to actively prepare for their pregnancy by guiding them towards a website ([www.wokewomen.nl](http://www.wokewomen.nl)) with practical and evidence-based information to help them improve their preconceptional health status. In addition, we encourage these women when there is a need for extra information to visit a healthcare provider for a PCC-consult.

Previous literature on social marketing strategies showed that it has the potential to improve diet, increase exercise and reduce substances-use like tobacco, and alcohol \[[@CR18]\]. Creating a social movement could raise awareness on the importance of PCC and could cause a supportive social environment for preconception health. In addition, research shows that healthcare collaborations in health promotion can result in effective and sustainable benefits for those involved \[[@CR45]\]. When effectively facilitated, healthcare collaborations can enable fundamental improvements to community development and health promotion.

Strengths of this stepped-wedge cluster RCT are the diversity of the population in the participating municipalities and the tailored intervention that complies with the heterogeneity of local settings. Moreover, the detailed questionnaire investigating respondents' lifestyle behaviours, health beliefs and the extent of planning of the current pregnancy based on validated questionnaires can be considered a strength of this study. In addition, the innovative social marketing strategy, the extensive process evaluation and the involvement of the prospective father highlight different and often neglected aspects of PCC-research.

A potential limitation of this study is the occurrence of selection bias, as participants who have actively prepared for their pregnancy are probably more eager to share their experience. However, in our previous feasibility study, response rates were high and the population characteristics were similar before and after introduction of the intervention \[[@CR13]\]. Another limitation is the selection strategy, as the respondents of this study are pregnant while the interventions focusses on the preconceptional period. Previous studies already showed that prospective parents are very difficult to identify and recruit, therefore almost all PCC related studies obtain information retrospectively \[[@CR46]\]. Finally, active participation of the healthcare providers is crucial to make the local PCC-pathway a success. Fortunately, the healthcare providers involved in the local PCC-pathway are driven to improve the awareness of PCC in their municipality and will be equipped to provide adequate PCC. All community midwifery practices have already been recruited and municipal policy makers are involved throughout the entire project.

With this study, we expect to effectively implement and evaluate a locally tailored PCC-approach. If this intervention will show to improve lifestyle behaviours, leading to improved pregnancy outcomes and future health of prospective parents and their offspring, it may be upscaled to (inter)national implementation.
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